Patent ID: 9096567
Filing Date: 2015-08-04
Classification: A61P,C07D

Abstract:
1. A method of treating an allergic inflammatory disease selected from asthma, dermatitis, allergic rhinitis, urticaria, anaphylaxis, angioedemea, allergies, contact hypersensitivity, drug hypersensitivity, and allergic conjunctivitis in a mammal, comprising administering a therapeutically effective amount of a compound of Formula I or a pharmaceutically acceptable salt thereof, to said mammal in need thereof, wherein: A A W is —C(═O)NR R L is a bond, —(CR m=0, 1 or 2; n=0 or 1; R R R R R or R hetCyc where t is 1 or 2 and p is 0 or 1, and the * indicates the point of attachment to G; G is Ar Ar —CH 2 N(1-3C alkyl) 2 , —O-(2-3C)fluoroalkyl, —O-(1-3C)difluoroalkyl —O-(1-3C)trifluoroalkyl, —OCH 2 (cyclopropyl), and (3-4C)alkynyl; Ar Ar Ar hetAr hetAr R R R